glp-1 liver fibrosis Why are agonists being used to treat patients with nonalcoholic fatty disease? Emerging Role of GLP-1 Receptor
Description
The more slowly food moves through your digestive tract, the smaller your appetite
Wegovy was also recently approved to treat noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults
Pharmacoepidemiology and Drug Safety
Without lifestyle changes, weight regain is common after discontinuing GLP-1 receptor agonists
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes
If you have a history of UTIs, this distinction is clinically significant
